Month: March 2022

Los Angeles, CA., March 28, 2022 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, announced today that its virtual-only shareholder update call is now scheduled for 3 p.m. PDT / 6 p.m. EDT on Thursday, March 31, 2022.. The shareholder update call will be facilitated by Draganfly CEO Cameron Chell, who will review the Company’s milestones; and CFO Paul Sun, who will review the Company’s financial results for FY 2021 and Q4 2021, which are planned to be filed after market on March 31, 2022. Draganfly President Scott Larson will be facilitating pre-submitted and live chat questions and answers. Registration for the call can be done here. The Company will answer pre-submitted questions at the conclusion of...

The Arrangement is expected to close on or about March 31, 2022 EDMONTON, Alberta, March 28, 2022 (GLOBE NEWSWIRE) — Alcanna Inc. (“Alcanna” or the “Company“) (TSX: CLIQ) announces today that all regulatory requirements under applicable provincial liquor and cannabis legislation have been satisfied for completion of the previously announced plan of arrangement (the “Arrangement“) with Sundial Growers Inc. (“Sundial“) (NASDAQ: SNDL) under section 192 of the Canada Business Corporations Act pursuant to the terms of the arrangement agreement between Alcanna and Sundial dated October 7, 2021, as amended by the amending agreement dated January 6, 2022 (the “Arrangement Agreement“). Sundial and Alcanna have mutually agreed to extend the outside date for closing of the Arrangement...

Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driverDupixent peak sales ambition raised to more than €13 billion Chronic obstructive pulmonary disease 2023 pivotal readouts provide potential for additional Dupixent sales ambition upgrade 13 potential new medicines currently in the clinic to treat chronic inflammatory diseases, with 17 readouts expected by the end of 2024Paris, March 28, 2022. Tomorrow, Sanofi will host an Immunology Investor Event with key members of the leadership team providing updates on how the company is advancing its Immunology strategy, including the ambition to more than quadruple Immunology franchise sales by the end of the decade. The focus of the event is on Dupixent® (dupilumab), a key growth driver, and Sanofi’s rapidly advancing pipeline, highlighting...

PLANO, Texas, March 28, 2022 (GLOBE NEWSWIRE) — European Wax Center, Inc. (NASDAQ:EWCZ) (together with its subsidiaries, the “Company”) today announced that it has priced $400 million of Series 2022-1 Class A-2 Fixed Rate Senior Secured Notes (the “Class A-2 Notes”) with an anticipated repayment term of five years, an aggregate principal amount of $400 million and a fixed interest rate of 5.50% per annum, payable quarterly. The Class A-2 Notes are expected to be issued by EWC Master Issuer LLC, a newly-formed, limited-purpose, bankruptcy remote indirect subsidiary of European Wax Center, Inc. in a privately placed securitization transaction. In addition to the Class A-2 Notes, the refinancing transaction is also expected to include a $40 million variable funding note facility (the “Variable Funding Notes”). As of the closing, none...

NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) — Woodgrain Inc. (“Parent”) announced today that its affiliate, HBP Merger Sub, Inc. (“Purchaser”), commenced the previously announced cash tender offer for all of the issued and outstanding shares of Common Stock (the “Shares”) of Huttig Building Products, Inc. (Nasdaq: HBP) (“Huttig”) at a price of $10.70 per share, net to the seller, in cash, without interest and less applicable withholding taxes. The tender offer is being made pursuant to the merger agreement (the “Merger Agreement”) executed on March 20, 2022 and announced by Woodgrain and Huttig on March 21, 2022. The $10.70 per share all-cash tender offer is being made pursuant to an Offer to Purchase dated March 28, 2022, and represents a premium of approximately 12.6% over Huttig’s closing share price on March 21, 2022, the last...

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or the “Company”) (TSXV:AME) is pleased to announce that the Board of Directors has approved the grant of stock options to directors, officers, employees and consultants of the Company allowing for the acquisition of up to, in the aggregate, 3,050,000 shares of the Company. The grant is a result of the Company’s annual compensation review and the issuance is made under the Company’s approved stock option plan. The options are exercisable at a price of $0.07 per share for a period of five years from the date of grant and are subject to regulatory policies. On Behalf of the Board,ABACUS MINING & EXPLORATION CORPORATION Paul G. Anderson, P.Geo.President and CEO About AbacusAbacus is a mineral exploration and mine...

CALGARY, Alberta, March 28, 2022 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to announce the most recent version of the Company’s monthly activity update can be found on the Company’s website at https://www.petrusresources.com/monthlyupdates. Additionally, further to the fully backstopped rights offering previously announced on March 24, 2022, the Company has posted instructions for Petrus shareholders wishing to subscribe to the offering. The directions can be found on the Company’s website at https://www.petrusresources.com/investor-relations. Any questions related to the rights offering can be directed to Odyssey Trust Company at (587) 885-0960 or 1 (888) 290-1175. ABOUT PETRUSPetrus is a public Canadian oil and gas company focused on property exploitation, strategic acquisitions...